» Articles » PMID: 10710201

Descriptive Epidemiology of Thyroid Cancer in Los Angeles County, 1972-1995

Overview
Specialties Oncology
Public Health
Date 2000 Mar 10
PMID 10710201
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To examine the descriptive epidemiologic features of incident thyroid cancers diagnosed among Los Angeles County residents between 1972 and 1995.

Methods: The Los Angeles County/University of Southern California Cancer Surveillance Program (CSP) collected data on 8820 newly diagnosed thyroid cancer of cases occurring in Los Angeles County. Average annual age-adjusted incidence rates were calculated to study the epidemiology of each of the major histologic types of thyroid carcinoma.

Results: For all races combined, the age-adjusted incidence rates were 2.5 per 100,000 males and 6.0 per 100,000 females. Differences in incidence by ethnicity were particularly striking, with Filipinos demonstrating the highest incidence rates (4.44 per 100,000 males, 11.3 per 100,000 females). Over the 23-year period, thyroid cancer incidence rates increased 1.5% per year for males and 1% per year for females. By histology, papillary carcinoma rates increased over time and follicular carcinoma rates decreased. Non-Spanish surnamed white men employed in certain white-collar occupations and radiologic technicians were at greater risk of thyroid cancer.

Conclusions: Additional research on the epidemiologic risk factors for thyroid cancer, particularly for gender and ethnicity, is needed to explain the marked elevated incidence rates among females and the Filipino population in Los Angeles County.

Citing Articles

Worse survival and higher rates of relapse in U.S. Armenians with papillary thyroid cancer.

Tsai K, Arca K, Ituarte P, Gernon T, Salehian B, Bell D Laryngoscope Investig Otolaryngol. 2024; 9(6):e70052.

PMID: 39713734 PMC: 11659813. DOI: 10.1002/lio2.70052.


Comparative analysis through propensity score matching in thyroid cancer: unveiling the impact of multiple malignancies.

Al-Ibraheem A, Abdlkadir A, Al-Adhami D, Lopci E, Al-Omari A, Al-Masri M Front Endocrinol (Lausanne). 2024; 15:1366935.

PMID: 38894738 PMC: 11184125. DOI: 10.3389/fendo.2024.1366935.


Clinical, cytological and ultrasonographic features of incidental thyroid cancer in a hospital-based study in vietnam.

Quang Nguyen B, Tran H, Nguyen H, Nguyen T, Nguyen T, Nguyen T Endocrinol Diabetes Metab. 2023; 6(3):e415.

PMID: 36896571 PMC: 10164435. DOI: 10.1002/edm2.415.


Characterization of mortality and high-risk characteristics of thyroid cancer in Filipinos using the California Cancer Registry.

Hsu R, Tsai K, Chennapan K, Wojcik K, Lee A, Nieva J Front Public Health. 2023; 10:1104607.

PMID: 36743179 PMC: 9893642. DOI: 10.3389/fpubh.2022.1104607.


Predictors of Response to Therapy Among Post Thyroidectomy Adult Filipino Patients with Papillary Thyroid Carcinoma Based on the 2015 American Thyroid Association Guidelines.

Santiago A, Isidro M, Parra J J ASEAN Fed Endocr Soc. 2021; 36(2):161-166.

PMID: 34966200 PMC: 8666484. DOI: 10.15605/jafes.036.02.18.